When it comes to growth investing, there are some key challenges that investors face. Jeremy Schwartz and Kara Marciscano explain how our just launched U.S. Growth & Momentum Fund (WGRO) seeks to solve for these challenges.
WisdomTree has collaborated with Dr. Jamie Metzl to help create the underlying Index that the BioRevolution Fund (WDNA) seeks to track. Dr. Metzl is the author of Hacking Darwin: Genetic Engineering and the Future of Humanity and a member of the World Health Organization’s advisory committee on human genome editing. Along with our Jeremy Schwartz, he discusses the BioRevolution, WDNA and the blurring lines between science fiction and our new reality.
The intersection of biology and technology health care is driving transformations. Kara Marciscano explains how our BioRevolution Fund (WDNA) allows investors to participate in the incremental changes driving the BioRevolution on a daily basis.
Changes are coming to our lives and world that may rival the industrial and internet revolutions. Jeremy Schwartz and Kara Marciscano discuss the BioRevolution already underway and identify the range of business sectors we believe are best positioned to benefit.
